Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cells.

Borovjagin AV, Dong J, Passineau MJ, Ren C, Lamani E, Mamaeva OA, Wu H, Keyser E, Murakami M, Chen S, MacDougall M.

PLoS One. 2011;6(10):e24281. doi: 10.1371/journal.pone.0024281. Epub 2011 Oct 7.

2.

A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.

Tsuruta Y, Pereboeva L, Glasgow JN, Rein DT, Kawakami Y, Alvarez RD, Rocconi RP, Siegal GP, Dent P, Fisher PB, Curiel DT.

Clin Cancer Res. 2007 May 1;13(9):2777-83.

3.

Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.

Zheng S, Ulasov IV, Han Y, Tyler MA, Zhu ZB, Lesniak MS.

J Gene Med. 2007 Mar;9(3):151-60.

PMID:
17351980
4.

Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.

Toh ML, Hong SS, van de Loo F, Franqueville L, Lindholm L, van den Berg W, Boulanger P, Miossec P.

J Immunol. 2005 Dec 1;175(11):7687-98.

5.

Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.

Van Houdt WJ, Wu H, Glasgow JN, Lamfers ML, Dirven CM, Gillespie GY, Curiel DT, Haviv YS.

Neuro Oncol. 2007 Jul;9(3):280-90. Epub 2007 May 23.

6.

Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.

Borovjagin AV, Krendelchtchikov A, Ramesh N, Yu DC, Douglas JT, Curiel DT.

Cancer Gene Ther. 2005 May;12(5):475-86.

PMID:
15706356
7.

Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency.

Wu H, Seki T, Dmitriev I, Uil T, Kashentseva E, Han T, Curiel DT.

Hum Gene Ther. 2002 Sep 1;13(13):1647-53.

PMID:
12228019
8.

Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.

Cripe TP, Dunphy EJ, Holub AD, Saini A, Vasi NH, Mahller YY, Collins MH, Snyder JD, Krasnykh V, Curiel DT, Wickham TJ, DeGregori J, Bergelson JM, Currier MA.

Cancer Res. 2001 Apr 1;61(7):2953-60.

9.

Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Koizumi N, Mizuguchi H, Sakurai F, Yamaguchi T, Watanabe Y, Hayakawa T.

J Virol. 2003 Dec;77(24):13062-72.

10.

Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini.

Xie J, Chiang L, Contreras J, Wu K, Garner JA, Medina-Kauwe L, Hamm-Alvarez SF.

J Virol. 2006 Dec;80(23):11833-51. Epub 2006 Sep 20.

11.

Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.

Schoggins JW, Nociari M, Philpott N, Falck-Pedersen E.

J Virol. 2005 Sep;79(18):11627-37.

12.

Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.

Hiwasa K, Nagaya H, Terao S, Acharya B, Hamada K, Mizuguchi H, Gotoh A.

Anticancer Res. 2012 Aug;32(8):3137-40. Erratum in: Anticancer Res. 2014 Jun;34(6):3231.

PMID:
22843884
13.

Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

Stevenson SC, Rollence M, Marshall-Neff J, McClelland A.

J Virol. 1997 Jun;71(6):4782-90.

14.

Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.

Lewis TB, Glasgow JN, Glandon AM, Curiel DT, Standaert DG.

PLoS One. 2010 Sep 17;5(9). pii: e12672. doi: 10.1371/journal.pone.0012672.

17.

A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.

Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT.

Gene Ther. 2005 Dec;12(23):1696-706.

PMID:
16034451
18.

Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.

Stoff-Khalili MA, Stoff A, Rivera AA, Mathis JM, Everts M, Wang M, Kawakami Y, Waehler R, Mathews QL, Yamamoto M, Rocconi RP, Siegal GP, Richter DF, Dall P, Zhu ZB, Curiel DT.

Cancer Biol Ther. 2005 Nov;4(11):1203-10. Epub 2005 Nov 8.

PMID:
16177567
19.

Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.

Stoff A, Rivera AA, Banerjee NS, Mathis JM, Espinosa-de-los-Monteros A, Le LP, De la Torre JI, Vasconez LO, Broker TR, Richter DF, Stoff-Khalili MA, Curiel DT.

Wound Repair Regen. 2006 Sep-Oct;14(5):608-17.

20.

Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.

Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J, Finberg R, Falck-Pedersen E, Crystal RG.

Am J Respir Cell Mol Biol. 1999 Mar;20(3):361-70.

PMID:
10030833
Items per page

Supplemental Content

Write to the Help Desk